More Gemini Features Coming to Google TV
Google TV integrates Gemini AI for image/video generation, enhances Google Photos, and adds a dedicated YouTube Shorts feed to the homepage.
Read moreThe open-source AlphaFold has been widely applied to find its use cases in real life, including the protein structure prediction of the COVID-19 pandemic—SARS-CoV-2.
Revolutionary changes have occurred in the field of life sciences through AI-based protein modeling predictions. In 2022, the protein folding model represented by Google DeepMind's AlphaFold paper was the most cited paper of the year.
Two years ago, Alphabet subsidiary Google DeepMind, based in London, provided a revolutionary answer to the "protein folding problem" that had lasted for decades in the history of AI research. This open-source AlphaFold can accurately predict the 3D model of protein structure from a one-dimensional amino acid sequence, accelerating research in the fields of biology and life sciences. Since then, this framework has been widely applied to find its use cases in real life, including the protein structure prediction of the COVID-19 pandemic—SARS-CoV-2.
Let's take a look at some interesting real-world applications of AlphaFold.
Matthew Higgins, a biochemist and molecular biology professor at the University of Oxford, is using AlphaFold to advance malaria vaccine development. The vaccine provides comprehensive protection against multiple stages of infection. Before the integration of AlphaFold, they were unable to understand the structure of the key protein Pfs48/45. By combining the predictive results of AlphaFold with traditional methods, the role of this protein has been clarified, aiding in vaccine design. Higgins acknowledges the occasional inaccuracies of AlphaFold but emphasizes its collaboration with other technologies. With a clear Pfs48/45 structure, they have entered the human trial phase. Higgins envisions the role of AlphaFold in novel protein design, enhancing vaccine development. This integration of AI tools into the project transforms it from basic science to the clinical stage, providing potential for the effectiveness of malaria vaccines.
Scientists have made significant breakthroughs by harnessing the extraordinary ability of a bacterium called Asymbiotica Photorhabdus to modify it for protein delivery into human cells. This breakthrough holds potential for delivering therapeutic proteins, including those used for gene editing. By using AlphaFold to modify the tail fibers of the injector, scientists have successfully attached it to human cells, enabling precise protein delivery. They customized the injector to bind with cancer cells, triggering their destruction without affecting other cells. Researchers used AlphaFold AI to modify the tail fibers for targeting cancer cells, effectively eliminating cancer cells while protecting other cells. A "tagging" technique allows the loading of toxins and gene-editing enzyme Cas9 onto the injector, triggering cell death or gene editing upon introduction into human cells. This adaptive approach demonstrates the potential for loading different proteins and increasing dosages. Additionally, AlphaFold helped modify the tail fibers to bind with mouse cells, successfully introducing fluorescent proteins into neurons. Although in the early stages, the researchers aim to optimize delivery efficiency and explore DNA/RNA payloads. This research showcases the role of AlphaFold in customizing injectors for targeted gene therapy.
A research team led by Alán Aspuru-Guzik, the director of the Acceleration Consortium at the University of Toronto, Nobel laureate Michael Levitt, and Alex Zhavoronkov, the founder and CEO of Insilico Medicine, has completely transformed drug development for hepatocellular carcinoma (HCC), a major type of liver cancer, using AlphaFold. This groundbreaking research utilized Insilico Medicine's automated drug design platform, Pharma.AI, based in New York. Leveraging protein structures derived from AlphaFold, they rapidly designed a potent inhibitor for a new HCC treatment pathway, completing this milestone research and synthesizing seven compounds in just 30 days. This heralds a new era of AI-driven therapy that will reshape healthcare and address critical medical needs.
Scientists Marcelo Sousa and Megan Mitchell from the University of Colorado Boulder are utilizing AlphaFold to combat antibiotic resistance mechanisms. Traditional methods have struggled to understand the enzyme structures responsible for resistance. AlphaFold's rapid and accurate protein structure predictions have unveiled a decade's worth of data secrets within minutes. Insights into these structures may pave the way for inhibiting resistance and maintaining antibiotic effectiveness. Marcelo Sousa and Megan Mitchell emphasize the potential of AlphaFold in addressing antibiotic resistance infections.
DeepMind collaborates with the non-profit organization Drugs for Neglected Diseases initiative (DNDi) to tackle neglected deadly diseases in developing countries, such as atopic dermatitis, sleeping sickness, and leishmaniasis. It has achieved considerable success in finding new treatment approaches for sleeping sickness. Notably, it replaced the toxic compound melarsoprol (causing one death in every 20 patients) with the safe drug fexinidazole as the new standard treatment for the disease.
Google TV integrates Gemini AI for image/video generation, enhances Google Photos, and adds a dedicated YouTube Shorts feed to the homepage.
Read moreAlphabet Q1 paid subscribers reached 350M, fueled by YouTube & Google One. YouTube ad revenue slightly missed at $9.88B amid Premium growth. Total Q1 revenue hit $109.9B, beating forecasts.
Read moreAnthropic releases Claude connectors for Adobe, Blender, and Ableton, enabling AI workflow automation and app control. It also sponsors the Blender Development Foundation.
Read moreApple introduces an App Store model splitting 12-month plans into monthly installments. On iOS 26.4+, it lowers upfront costs without reducing total price, adding billing tracking.
Read moreGoogle launches Aadhaar digital IDs in Wallet for India, enabling secure QR/NFC verification. A phased partner rollout targets key sectors, while passport-based credentials expand globally.
Read moreYouTube tests "Ask YouTube," an AI tool blending text and video for complex queries. Initially for US Premium users, it supports interactive follow-ups, expanding Google's AI search.
Read moreGoogle grants US DoD classified AI access, joining OpenAI and xAI in defense deals amid Anthropic's dispute. Contractual safeguards against surveillance and lethal weapons remain unenforceable.
Read moreMistral AI launches Workflows, a Temporal-powered orchestration platform for secure, Python-driven enterprise AI automation featuring human-in-the-loop approvals.
Read moreCustom subliminal audio maker

AI Social Media Manager

AI Search Visibility

Workout and Calorie Tracker
Stock research platform

AI interview assistant

Scientific figure generator

AI courses with real code